JLL Partners-Backed Patheon Said to Aim for IPO This Month

Patheon NV, the Dutch maker of drug ingredients that filed for a U.S. initial public offering more than a year ago, may move ahead with the listing this month, a person with knowledge of the matter said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.